CD8A and non-small cell lung carcinoma: Isobe et al. demonstrated an integrated immune response consisting of immunoglobulin G (IgG) antibodies, CD4 and CD8 T cells against a NY-ESO-1-expressing NSCLC experiencing SR [12].